chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Four - five months subsequent to receiving a second dose of varicella virus vaccine live, a pregnancy screening indicated that the pt failed to seroconvert.
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.
pt had arm pain, bruise, itching at site of injection. took ibuprofen to help with pain
Fushing of face by 4:15pm Slight headache by 5:30 No fever Slept from 7pm to 6:00am the next day. 3/12/21 Headache intensified around 10am Slept on and off all day No fever During the night had a few chills 3/13/21 Headache has lessened Body is weak
Subsequent to receiving first and second dose of varicella virus vaccine live the pts serum VZV antibody test revealed a lack of seroconversion.
Flu-like illness.  06/01: Malaise.  06/02: muscle aches (entire body).
This was my second shot.  On my 2nd day I could not lift my left arm.   I could not lift it forward or to the side not even 1/2 an inch.  Extremely painful to the touch.  I  had difficulties getting dressed, driving , working and horrible time sleeping due to the pain of the arm. This continued and saw my Dr. who gave me pain med  naproxen 500mg.   It helped slightly just taking edge off.  After a horrible weekend I began using a heating pad and that seems to be helping.  On Tuesday the 20th I had first sign of improvement.  I was able to move my left arm to the side at a greater degree and the sensitivity to the skin is subsiding.  I still cannot lift it forward and have an appointment scheduled with a specialist.
Injection site pain; Aches / muscle soreness in ribs, neck, shoulders, opposite arm and abdomen.; Joint pain in one knee; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7534), via an unspecified route of administration in the left arm on 22Mar2021 at 08:45 (at the age of 49-years-old), as a single dose for COVID-19 immunisation. Medical history included auto immune hepatitis and COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. The patient previously received sulfa drugs (unspecified) and doxycycline (MANUFACTURER UNKNOWN) for an unspecified indication and experienced allergy. Concomitant medications included azathioprine (IMURAN) 50 mg, acetylsalicylic acid (ASPIRIN), levothyroxine (SYNTHROID) and venlafaxine hydrochloride (EFFEXOR); all for unknown indications received within two weeks of vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 22March2021 at 14:00, the patient experienced injection site pain; aches or muscle soreness in ribs, neck, shoulders, opposite arm and abdomen; joint pain in one knee and fatigue. The patient did not receive any treatment for the reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the injection site pain, muscle soreness, joint pain in one knee and fatigue were resolving.  No follow up attempts are needed. No further information is expected.
Severe symptoms of Guillain-Barre syndrome.  Began July 1.  Admitted to hospital July 2, Numbness on left side began as tingling in both legs.  Outcome still in doubt this is ongoing.
8/26/16 patient received vaccines. 8/27/16 patient presented to ER with urticaria.
Myalgia, NauseaVomiting, Tachycardia, hypoxia, chills Narrative:
I had a sore arm after receiving the vaccine for about a day. I tested positive for COVID-19 on 03/20/2023. I contacted my doctor and a prescription for Paxlovid.  I tolerated the medication without any complications. It took a while for the tiredness to go away but I am feeling better.
Itching of rash; Little patches like pimple size on body/ arms, legs, torso, neck; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itching of rash) and DERMATITIS ACNEIFORM (Little patches like pimple size on body/ arms, legs, torso, neck) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced RASH PRURITIC (Itching of rash) and DERMATITIS ACNEIFORM (Little patches like pimple size on body/ arms, legs, torso, neck). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (Itching of rash) and DERMATITIS ACNEIFORM (Little patches like pimple size on body/ arms, legs, torso, neck) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.
Several hours after vaccination, mother reports that child suddenly began to have fever, nasal congestion, rhinorrhea, + diarrhea. Fever was recorded up to 104. We saw pt in clinic 11/8/19 and his temperature was normal although diarrhea was persisting. Mother was instructed to push fluids.
Client stated that headache began within 15 minutes of receiving first Moderna dose while in the observation room.  Client then stated when she arrived home her symptoms then proceeded with vomiting several times that night, body aches, fever of 39-40 degrees Celsius, Left deltoid pain and rash at injection site. Client stated, "I had to take tylenol 500 mg twice, first dose I took before bed for my fever, pain, and body aches. I applied vapor rub ointment to my rash on my left shoulder where I received the vaccine." Injection site pain and rash lasted for 1 day. Headache and body aches lasted for 3 days. Client denied taking any antihistamine medication for symptoms. Client stated, "At the time of vaccination I did not know I was pregnant. Shortly after I found out and confirmed that I was indeed pregnant during my first dose vaccination." Client denied having any current medical conditions and medications. Client stated that she was hypertensive during her previous pregnancy 9 years ago and would take an Ace inhibitor medication (stated the medication in Spanish as "alonopril" but unable to determine English equivalent). Client had concerns today during second Moderna dose due to still being pregnant and whether or not she should proceed with vaccination. At 5:03 PM Co Lead PHN notified  PHN and stated that there are no contraindications with pregnancy and 30 minute observation would be recommended. It is unknown if the symptoms after first dose of Moderna are unknown due to pregnancy or due to the covid-19 Moderna vaccination. Co Lead PHN relayed observation guidance and recommendations to client and her husband. Client and husband were in agreement to proceed with vaccination at 5:17 PM. Client completed 30 minute observation and was seen exiting facility safely with steady gait and husband at her side.
pt recv vax MAY93 & JUN93 pt devel elevated liver function tests & pos core antibody; f/u MD stated that the pt devel serologic changes consistent w/Hep B & felt that pt's liver function changes were not vax related;
Pt. Deceased  1st/2nd Dose Janssen -- 1802068 - 3/25/2021
Patient developed a high fever of 104 14 hours post vaccination .Was in low responsive state .Would not walk talk or eat for several hours.
15 minutes after injection: c/o itching throat, chest tightness. 20 minutes: cough, itching eyes,nasal discharge. 25 minutes: bright red rash over entire body and shaking. Medications given at onset of reaction: Benadryl 50mg po, Prednisone 40mg po(1 tablet chewed other swallowed), Zantac 150mg po, Albuterol Inhaler-2 puffs. Symptoms relieved with above meds.
injection site black in color; itchy; her injection site is swollen; injection site red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (injection site black in color), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (her injection site is swollen) and VACCINATION SITE ERYTHEMA (injection site red) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 04UA21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021 at 10:00 AM, the patient experienced VACCINATION SITE DISCOLOURATION (injection site black in color), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (her injection site is swollen) and VACCINATION SITE ERYTHEMA (injection site red). On 12-Mar-2021, VACCINATION SITE DISCOLOURATION (injection site black in color), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (her injection site is swollen) and VACCINATION SITE ERYTHEMA (injection site red) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  No concomitant medications were reported.  Patient reported that she did not take any medication to treat the symptoms.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Follow-up was received on 05-MAY-2021. Second dose batch number was added.
The Monovalent COVID-19 vaccine was inadvertently given to the patient who was scheduled to receive the Bivalent COVID-19 vaccination as per the recent FDA approval of the Bivalent COVID-19 vaccines.  The patient was notified of the error on the same day of the incident and written communication is being drafted and sent to all patients reiterating what was discussed over the phone with the patient. Further action is underway with the guidance of the CDC Interim Clinical Considerations for using COVID-19 Vaccines.  All patients were instructed to follow up with their primary care physician and were offered the opportunity to receive a booster dosage in line with the recommendations of the FDA.
No immediate symptoms but after a week, injection area is red and itchy.  It looks like a band of red on my left arm.  Seems to be dissipating after a couple of days but still a little itchy and still red.
i went into violent convulsions; This serious case was reported by a consumer via interactive digital media and described the occurrence of convulsion in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  On 01-SEP-2022, the patient received Shingles vaccine. On 02-SEP-2022, 1 days after receiving Shingles vaccine, the patient experienced convulsion (Verbatim: i went into violent convulsions) (serious criteria GSK medically significant).  The outcome of the convulsion was not reported.  It was unknown if the reporter considered the convulsion to be related to Shingles vaccine.  It was unknown if the company considered the convulsion to be related to Shingles vaccine.  Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient stated that, he/she took the shingles vaccine. On September 2, exactly 24 hour later, he/she went into violent convulsions. The reporter had stated that, he/she would never again would take any kind of vaccine. The follow up would not possible, as no contact details were available.
Nausea, chills, headache, fever, and congestion a little iver 24 hours after my second vaccine.
This spontaneous report was received from a registered pharmacist, and refers to an adult patient in 50's. The information about patient's concurrent condition, medical and drug history and concomitant medications were unknown. On 03-DEC-2021, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II), rHA, dose: 0.5 ml, lot # S022754, expiration date: 22-JUL-2021 as prophylaxis (anatomical location were not provided) (expired product administered). The measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) did not undergone any temperature excursions. No other adverse events were reported.
Pain to injection site and radiate to shoulder. Very limited range of motion to shoulder  - unable to take shirt off herself, and increased pain. 2.4.12 - getting better slowly.
Received vaccination on Saturday 6/22/19, noticed on Thursday 6/27/19 that injection site was warm to touch, large red circle surrounding the injection site
Weak; Nausea; Vomiting; Fever; Headache; This spontaneous case was reported by a patient and describes the occurrence of ASTHENIA (Weak), NAUSEA (Nausea), VOMITING (Vomiting), PYREXIA (Fever) and HEADACHE (Headache) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product MACITENTAN for Pulmonary arterial hypertension.    Concurrent medical conditions included Pulmonary arterial hypertension.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and MACITENTAN (Oral) at an unspecified dose. On an unknown date, the patient experienced ASTHENIA (Weak), NAUSEA (Nausea), VOMITING (Vomiting), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, ASTHENIA (Weak), NAUSEA (Nausea), VOMITING (Vomiting), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  No concomitant medication was provided.  No treatment medication was provided.
This case was reported by a nurse and described a 28 year old female patient who did not respond to immunization with hepatitis B vaccine recombinant (Engerix B). On May 19 2003, the patient received the first dose of Engerix B (lot ENG529292 incorrect lot number). On 6/23/2006, the patient received the second dose of Engerix B (lot ENG529292 incorrect lot number). Approximately 20 months later, on 2/19/2005, a hepatitis B surface antibody titer was negative. The patient was seen at a physicians office. Report received via manufacturer.
Late in the evening on 5/21/2022, I developed a cough and a sore throat, which felt almost like strep throat. The following morning on 5/22/2022, I was hoarse. I took my temperature, and it was 99 degrees, which is high for me. My eyes felt strange and I felt kind of lethargic, so I took a home COVID test, and the result was positive. This was a breakthrough case. That day, I decided to go to Urgent Care to get a rapid test done, and the result was again positive. On 5/23/2022, I still felt lethargic, so I rested at home. I had chicken soup and cough syrup delivered, and the cough syrup worked really well. On that day, I actually felt well enough to walk my dog. For the rest of the week, I felt fine. At the time of this writing, I still have a little residual cough, but I haven't felt the need to take the cough syrup.
On 08/14/2000 the patient experienced a "breakthrough rash of approximately 8-10 lesions". It was noted that the patient was afebrile and had "no other adverse effects". The patient's twin sister was also vaccinated on the same day and did not develop a rash. Follow up information from a health care professional reported that the patient had 10-15 pustules at most and that on an unspecified date recovered from the rash. No further information is expected.
Patient continues to experience soreness 2 weeks after the FLUZONE QUAD was administered. Soreness experienced from should to half way down to elbow.
HYPOXIA 4/9/2023 CHRONIC LOW BACK PAIN > 3 MONTHS
Patient came in to inform us of a swollen arm the day after the vaccine was administered. Arm was swollen down to and including the hand.
At 10 pm night of vaccine, began to get itchy and mild rash on forearms. Relieved by benadryl. On 5/11 rash throughout day mostly relieved with benadryl. Throughout evening on 5/11 worsening rash and hives forming by 11 pm on neck, face, hands, upper arms, abdomen, thighs, and upper feet. Little to no relief with benadryl. Went to urgent care 5/12, rash as before except now palms of hands red and rash now on buttocks and in groin. Started on oral prednisone, cortisone cream. 1st dose of prednisone with moderate fading of rash and mostly relieved itching.
cheek and mouth and tongue (lateral) soreness. Acidic foods bothersome. 7/16 crescendo to 7/20/04 worst day. Self resolved to normal by 7/21. 5d duration.
This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 69-year-old female patient who received SHINGRIX (batch number B5EK2, expiry date 28th April 2020). On 23rd April 2018 11:45, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In April 2018, several hours after receiving SHINGRIX, the patient experienced pain in arm (serious criteria other: Serious as per reporter), injected limb mobility decreased (serious criteria other: Serious as per reporter) and numbness of extremities (serious criteria other: Serious as per reporter). On 23rd April 2018, the patient experienced vaccine administered at inappropriate site. On an unknown date, the outcome of the pain in arm, injected limb mobility decreased and numbness of extremities were recovered/resolved and the outcome of the vaccine administered at inappropriate site was unknown. The reporter considered the pain in arm, injected limb mobility decreased and numbness of extremities to be probably related to SHINGRIX. Additional details were provided as follows: The retail pharmacist stated that the patient received SHINGRIX and complained of left arm numbness, pain, decreased range of motion the day of or day after administration (left arm site of administration). The pharmacist stated the physician reported the patient received this dose of SHINGRIX in the bursa of the left shoulder, documented at pharmacy as left deltoid, which led to vaccine administered at inappropriate site. The patient sought physician for treatment on 24th April 2018, prescribed MOBIC. The patient required emergency room visit. The pharmacist stated the patient reported all symptoms were resolved at the time of reporting. The pharmacist gave permission for contact if there were further questions.
Per patient's mother: approximately 10 minutes post-vaccination, the patient slumped out of the chair onto the floor and experienced a seizure that lasted 10 to 15 seconds.  Our technician noticed the patient on the floor in the waiting area and notified the pharmacists on duty, but the patient was no longer actively seizing.  Pharmacists checked in with the patient and mother and he was conscious and able to answer basic questions( date, location...) and expressed that he felt completely fine.  Mother was still concerned and stated that she wanted to take him to a local pediatric hospital but that she did not feel it necessary to call EMT/ambulance.
Almost exactly 24 hours post injection of 2d dose of Moderna vaccine, became dizzy, laid down, fell asleep/passed out for 3 hours. Woke refreshed., no residual effects.  No other mitigating factors were noted e.g. no drugs/diet/exercise changes .  No intervention  was needed.
Patient presented to pharmacy for second moderna covid shot. She informed us that she had experienced a rash around the injection site that began about 1 week after the injection and lasted for about 5 days. She did not experience any issues other than sore arm. The rash was localized around the injection site and then a ring  appeared around the injection site. No welts, no itch, no bothering the patient.
Got period two days ago but today a little heavier; Tiredness; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (Got period two days ago but today a little heavier), FATIGUE (Tiredness) and MYALGIA (Soreness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEAVY MENSTRUAL BLEEDING (Got period two days ago but today a little heavier), FATIGUE (Tiredness) and MYALGIA (Soreness). At the time of the report, HEAVY MENSTRUAL BLEEDING (Got period two days ago but today a little heavier), FATIGUE (Tiredness) and MYALGIA (Soreness) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No concomitant medication was  reported.  No treatment medication was reported.
Patient vomited x1 approximately  10  minutes after vaccine. Reported once vomited felt somewhat better. Instructed patient to remain 30 minutes for monitoring. O2 Sat- 98% on room air, Heart rate-78 Blood pressure 107/78. Patient vomited once again 20 minutes later, Zofan 4mg ODT given. Patient became pale, diaphoretic, and complained of chest heaviness/burning. Patient agreed to seek Emergency department treatment. ED advised patient would be arriving per car. ED is located across the street. Less than a minute away. Transported to ED per father private car.  Awake, oriented, and answering questions without difficulty upon leaving vaccination site.
About a week after receiving my 1st Pfizer shot, I started getting stiffness and pain in my upper left thigh area. I went to an Urgent Care facility of the advice of my doctor. I was examined by a Family Nurse Practitioner who determined that my leg muscles may have been inflamed due to the vaccine. She prescribed a NSAID and said to return if symptoms persisted or grew worse.  Her concern was that blood clotting in the leg might occur. The symptoms continued, working downwards in my left leg, causing more stiffness and immobility. Upon being examined by my Primary Doctor, he refused to believe that the vaccine had anything to do with my worsening symptoms. He declared I had a sciatic nerve condition and should take steroids. When I asked if an ultrasound might be worthwhile due to my concern of a DVT blood clot, he argued with me and said to the steroids first, and then "we'll see" about getting an ultrasound. i am now trying to get a second opinion of my condition.
Headache, rash (redness) on chest, shoulders, face, sense of high fever but temperature was normal